Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00207259 · ClinicalTrials.gov registry record · NA

Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00207259: Completed NA study, sponsored by Brigham and Women's Hospital.

NCT00207259 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00207259, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for prostate cancer. Generally, we would like to examine the feasibility of studying Reiki and RRT with CR in patients with prostate cancer, and to obtain preliminary results on the effectiveness of these treatments compared to controls. Specific objectives: 1. Determine the proportion of eligible patients who agree to participate in the study 2. Measure compliance with CAM therapy interventions 3. Measure compliance with physiologic and psychological outcome measurement assessments 4. Assess differences between experimental and control groups on measures on depression, anxiety, quality of life, salivary cortisol levels and an immunomarkers

Primary Outcome

QOL testing performed at four time points

Interventions

  • BEHAVIORAL Reiki & Relaxation Response Therapy with Cognitive Restructuring

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2005-03
Est. Completion 2017-06-15
Phase NA
Brigham and Women's Hospital

937 total trials

What the finished NCT00207259 record still lists

NCT00207259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Reiki & Relaxation Response Therapy with Cognitive Restructuring is the first listed.

NCT00207259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00207259 about?

NCT00207259 is a clinical study titled "Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial". Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for prostate cancer. Gene...

What is the current status of trial NCT00207259?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2005-03. Estimated completion is 2017-06-15.

What interventions are being tested in trial NCT00207259?

The interventions under investigation include: Reiki & Relaxation Response Therapy with Cognitive Restructuring (BEHAVIORAL).

Who is sponsoring clinical trial NCT00207259?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00207259's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00207259, the US trial registry maintained by the National Library of Medicine. NCT00207259 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.